SE0002831L - Behandling av kroniska inflammatoriska sjukdomar i mag-tarmkanalen - Google Patents

Behandling av kroniska inflammatoriska sjukdomar i mag-tarmkanalen

Info

Publication number
SE0002831L
SE0002831L SE0002831A SE0002831A SE0002831L SE 0002831 L SE0002831 L SE 0002831L SE 0002831 A SE0002831 A SE 0002831A SE 0002831 A SE0002831 A SE 0002831A SE 0002831 L SE0002831 L SE 0002831L
Authority
SE
Sweden
Prior art keywords
treatment
gastrointestinal tract
inflammatory diseases
chronic inflammatory
treating gastrointestinal
Prior art date
Application number
SE0002831A
Other languages
Unknown language ( )
English (en)
Other versions
SE0002831D0 (sv
Inventor
Joel Bolonick
Alan Stewart
Original Assignee
Joel Bolonick
Alan Stewart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joel Bolonick, Alan Stewart filed Critical Joel Bolonick
Publication of SE0002831D0 publication Critical patent/SE0002831D0/sv
Publication of SE0002831L publication Critical patent/SE0002831L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE0002831A 1998-02-09 2000-08-07 Behandling av kroniska inflammatoriska sjukdomar i mag-tarmkanalen SE0002831L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/002265 WO1999039699A1 (en) 1998-02-09 1998-02-09 Treatment of chronic inflammatory disorders of the gastrointestinal tract

Publications (2)

Publication Number Publication Date
SE0002831D0 SE0002831D0 (sv) 2000-08-07
SE0002831L true SE0002831L (sv) 2000-09-28

Family

ID=22266344

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0002831A SE0002831L (sv) 1998-02-09 2000-08-07 Behandling av kroniska inflammatoriska sjukdomar i mag-tarmkanalen

Country Status (9)

Country Link
EP (1) EP1052977A4 (sv)
JP (1) JP2002502812A (sv)
KR (1) KR20010040646A (sv)
CN (1) CN1149078C (sv)
AU (1) AU735084B2 (sv)
CA (1) CA2320087C (sv)
IL (1) IL137598A (sv)
SE (1) SE0002831L (sv)
WO (1) WO1999039699A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100333727C (zh) * 2004-11-25 2007-08-29 天津药业研究院有限公司 布地奈德靶向微丸及其制备方法
MD2852C2 (ro) * 2005-03-28 2006-04-30 Георге АНГЕЛИЧ Utilizarea budesonidei pentru tratamentul ascitei rezistente la pacienţii cu ciroză hepatică
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2008099615A1 (ja) * 2007-02-16 2008-08-21 Aska Pharmaceutical Co., Ltd. 微粒子油性懸濁液を含む医薬組成物
WO2009064819A2 (en) 2007-11-13 2009-05-22 Meritage Pharma, Inc. Compositions for the treatment of gastrointestinal inflammation
US9050368B2 (en) 2007-11-13 2015-06-09 Meritage Pharma, Inc. Corticosteroid compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
HU227519B1 (en) * 1991-12-18 2011-07-28 Astra Ab Synergic pharmaceutical composition containing combination of formoterol and budesonide
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
GB9412394D0 (en) * 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
CN1088584C (zh) * 1996-08-02 2002-08-07 久光制药株式会社 口服制剂用胶囊及口服胶囊制剂
KR100219918B1 (ko) * 1997-07-03 1999-09-01 김윤 대장선택적 약물전달용 조성물

Also Published As

Publication number Publication date
SE0002831D0 (sv) 2000-08-07
IL137598A0 (en) 2001-07-24
CN1284869A (zh) 2001-02-21
EP1052977A4 (en) 2006-07-12
KR20010040646A (ko) 2001-05-15
AU6320098A (en) 1999-08-23
AU735084B2 (en) 2001-06-28
JP2002502812A (ja) 2002-01-29
CA2320087A1 (en) 1999-08-12
IL137598A (en) 2005-09-25
CA2320087C (en) 2006-12-19
EP1052977A1 (en) 2000-11-22
CN1149078C (zh) 2004-05-12
WO1999039699A1 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
Abdollahi et al. A review of drug-induced oral reactions
BR9814378A (pt) Forma de dosagem de liberação prolongada farmacêutica revestida entérica de um inibidor de h+, k+-atpase, processos para a manufatura da mesma, para melhorar a inibição de secreção de ácido gástrico, para melhorar o efeito terapêutico no tratamento de distúrbios gastrointentinais, para receber um perfil de plasma prolongado de um inibidor da h+, k+-atpase, e, usos de uma composição farmacêutica e de inibidor da h+, k+-atpase
ATE522211T1 (de) Stabilisierte fibrat-mikropartikel
EP1392321A4 (en) METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES OF DIGESTIVE STRENGTH WITH TOPIC EFFECTIVE CORTICOSTEROIDS
TR200002207T1 (tr) Slekoksib bileşikleri.
JP2011502995A (ja) アンドログラフィス・パニキュラータ抽出物
ATE319457T1 (de) Behandlung iatrogenen und altersbedingten bluthochdruck mit vitamin b6-derivative, und pharmazeutische zusammensetzungen verwendbar dazu
ATE357216T1 (de) Fibrat-statin kombinationen mit verminderten von der nahrungsaufnahme abhängigen auswirkungen
FR2445146A1 (fr) Medicament a prise orale contenant une substance inhibitrice de l'inflammation et un ou plusieurs phospholipides
WO2003068171A3 (en) Method and composition for treatment of inflammation and aids-associated neurological disorders
MX2022011748A (es) Composiciones orales de inhibidor de ruta de mk2 para el tratamiento de condiciones inmunitarias.
Lee et al. Prevention of NSAID-associated gastroduodenal injury in healthy volunteers-a randomized, double-blind, multicenter study comparing DA-9601 with misoprostol
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
SE0002831L (sv) Behandling av kroniska inflammatoriska sjukdomar i mag-tarmkanalen
JP5584713B2 (ja) アズレンスルホン酸ナトリウムを主剤とする点鼻薬
US8557310B2 (en) Composition to retard the onset of symptoms of alzheimer's disease
US4405610A (en) Drug for curing inflammatory and/or degenerative and/or atrophic mucous-membrane diseases
ITMI972690A1 (it) Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-arteriosclerotici
HUP9900978A2 (hu) Dioszgenint tartalmazó készítmény
MX2021004198A (es) Suplemento dietetico humano y metodo para tratar trastornos del sistema digestivo y los relacionados con el sistema inmunologico.
JP2003516309A (ja) 涙液分泌障害を除く外分泌障害処置剤
El-Koshairy et al. The effect of lead toxicity on albino rats’ filiform and fungiform papillae and the possible protective role of honey and black seed
Hudson Recurrent aphthous stomatitis: diagnosis and management in primary care
JP5272384B2 (ja) 口腔粘膜疾患の治療剤
Lindström et al. Isolated rat stomach ECL cells generate prostaglandin E2 in response to interleukin-1β, tumor necrosis factor-α and bradykinin

Legal Events

Date Code Title Description
NAV Patent application has lapsed